Seres Therapeutics Inc (MCRB) is up Thursday morning, with the stock increasing 0.99% in pre-market trading to 1.02. MCRB's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 89 out of 146 industries, the stock ranks higher than 1% of stocks. Seres Therapeutics Inc has fallen 7.34% over the past month, closing at $1.03 on February 8. During this period of time, the stock fell as low as $1.03 and as high as $1.24. MCRB has an average analyst recommendation of Strong Buy. The company has an average price target of $11.00.
MCRB has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on MCRB!